Inactive Instrument

Insiders Nanomix Corporation

Stocks

NNMX

US63008H2013

Advanced Medical Equipment & Technology

Insiders

25/23/25	Nanomix Corporation Announces Chief Executive Officer Changes	CI
31/22/31	Nanomix Names Tadd S. Lazarus to Board of Directors	CI
31/22/31	Nanomix Corporation Appoints Tadd S. Lazarus to its Board of Directors as Independent Director	CI
26/22/26	Nanomix Corporation Appoints Thomas Schlumpberger as Member of the Board of Directors	CI
26/22/26	Nanomix Corporation Announces Executive Changes	CI
30/22/30	Nanomix Corporation Appoints Vidur Sahney as Chief Operating Officer	CI
11/21/11	Boston Therapeutics, Inc. Announces Board Changes	CI
11/21/11	Boston Therapeutics, Inc. Announces Resignation of Conroy Cheng, as Its Chief Executive Officer	CI
11/20/11	Boston Therapeutics, Inc. Appoints Conroy Cheng as the Interim Chief Executive Officer and Interim Chief Financial Officer	CI
25/19/25	Boston Therapeutics, Inc Announces Resignation of S. Colin Neill as Member of Board and Audit Committee	CI
07/18/07	Boston Therapeutics, Inc. Announces Resignation of Loraine V. Upham as Chief Operating Officer	CI
29/18/29	Boston Therapeutics, Inc. Announces Board Changes	CI
27/18/27	Boston Therapeutics Creates New Scientific Advisory Board	CI
20/18/20	Boston Therapeutics, Inc Announces New Coo, Loraine V. Upham	CI
19/17/19	Rom Eliaz Resigns as Director of Boston Therapeutics, Inc	CI
01/16/01	Boston Therapeutics, Inc. Appoints Carl W. Rausch as Director	CI
16/16/16	Alan M. Hoberman Resigns as Director of Boston Therapeutics, Inc	CI
03/16/03	Boston Therapeutics, Inc. Appoints Carl W. Rausch as Chief Executive Officer	CI
21/16/21	Boston Therapeutics, Inc. Announces Resignation of Dale H. Conaway as Director and as Member of Each of the Committees	CI
14/16/14	Henry J. Esber, Resigns as Director and as Member of Each of the Committees of Boston Therapeutics	CI
11/16/11	David Platt Resigns from Boston Therapeutics, Inc. as Chairman and Director	CI
23/16/23	Boston Therapeutics, Inc. Announces Executive Changes	CI
05/15/05	Boston Therapeutics, Inc. Announces Executive Changes	CI
17/15/17	Nanomix Appoints Larry K. Wray, Ph.D. as VP of Development	CI
17/14/17	Nanomix, Inc. Appoints Tom Richards as Senior Advisor	CI